Atorvastatin News and Research

RSS
SAR236553/REGN727 antibody reduces LDL by up to 72% in patients

SAR236553/REGN727 antibody reduces LDL by up to 72% in patients

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C

Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C

New cholesterol lowering drugs on the horizon

New cholesterol lowering drugs on the horizon

Merck fails to get FDA nod for new cholesterol lowering combo pill

Merck fails to get FDA nod for new cholesterol lowering combo pill

Making a medicinewise choice between brands

Making a medicinewise choice between brands

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron reports total revenues of $123.0M for fourth quarter 2011

FDA grants Mylan tentative approval for Atorvastatin Calcium ANDA

FDA grants Mylan tentative approval for Atorvastatin Calcium ANDA

Cost paid for statins 400% higher in the U.S. than U.K.

Cost paid for statins 400% higher in the U.S. than U.K.

Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets

Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets

Ranbaxy signs consent decree with U.S. FDA

Ranbaxy signs consent decree with U.S. FDA

Viewpoints: Politics overtakes Plan B; Gingrich's entitlement plans; Cheeseburgers and death

Viewpoints: Politics overtakes Plan B; Gingrich's entitlement plans; Cheeseburgers and death

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.

Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S.

Ranbaxy receives FDA approval to manufacture and market generic Lipitor

Ranbaxy receives FDA approval to manufacture and market generic Lipitor

Ranbaxy and Teva announce generic Lipitor agreement

Ranbaxy and Teva announce generic Lipitor agreement

Watson commences shipping of generic LIPITOR

Watson commences shipping of generic LIPITOR

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor

Pfizer backs its highest grosser Lipitor

Pfizer backs its highest grosser Lipitor

HealthWarehouse.com launches pre-order program for generic Lipitor

HealthWarehouse.com launches pre-order program for generic Lipitor

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD